Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers
Data up to Jan 2025
Total Citations Per Year
Abstract
References (42)
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
1994 • 2,529 citations
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
1994 • 1,899 citations
Genotypic and Phenotypic Characterization of HIV-1 Patients with Primary Infection
1993 • 1,258 citations
Cytotoxic T-Cell Immunity to Influenza
1983 • 932 citations
HIV-specific cytotoxic T lymphocytes in seropositive individuals
1987 • 797 citations
Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.
1985 • 789 citations
Serine phosphorylation-independent downregulation of cell-surface CD4 by nef
1991 • 760 citations
HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
1995 • 750 citations
Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.
1995 • 650 citations
Selective Transmission of Human Immunodeficiency Virus Type-1 Variants from Mothers to Infants
1992 • 598 citations
Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.
1996 • 520 citations
HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides
1988 • 447 citations
Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1
1996 • 440 citations
Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
1993 • 427 citations
HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant
1993 • 368 citations
Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus‐1‐infected mothers
1992 • 221 citations
Isometric Muscle Strength in Youth Assessed by Hand-held Dynamometry
2011 • 212 citations
Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein.
1993 • 196 citations
Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope.
1994 • 179 citations
HIV Type 1 Variation in World Health Organization-Sponsored Vaccine Evaluation Sites: Genetic Screening, Sequence Analysis, and Preliminary Biological Characterization of Selected Viral Strains
1994 • 176 citations
Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4
1988 • 173 citations
Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus
1990 • 172 citations
Augmentation of Human Immunodeficiency Virus Type 1 Neutralizing Antibody by Priming with gp160 Recombinant Vaccinia and Boosting with gp160 in Vaccinia-Naive Adults
1993 • 160 citations
A Prime-Boost Approach to HIV Preventive Vaccine Using a Recombinant Canarypox Virus Expressing Glycoprotein 160 (MN) followed by a Recombinant Glycoprotein 160 (MN/LAI)
1995 • 144 citations
CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity.
1990 • 120 citations
Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Cytolytic T Lymphocyte Responses in Seronegative Adults by a Nonreplicating, Host-Range-Restricted Canarypox Vector (ALVAC) Carrying the HIV-1MN env Gene
1995 • 102 citations
Recombinant Vaccinia Viruses As Vectors for Studying T Lymphocyte Specificity and Function
1990 • 94 citations
Safety and Immunogenicity of a Candidate HIV-1 Vaccine in Healthy Adults: Recombinant Glycoprotein (rgp) 120: A Randomized, Double-Blind Trial
1996 • 90 citations
Lack of induction of antibodies specific for conserved, discontinuous epitopes of HIV-1 envelope glycoprotein by candidate AIDS vaccines.
1995 • 87 citations
Vaccinia Virus Expression Vector: Coexpression of β-Galactosidase Provides Visual Screening of Recombinant Virus Plaques
1985 • 76 citations
Safety and Immunogenicity of Env 2-3, a Human Immunodeficiency Virus Type 1 Candidate Vaccine, in Combination with a Novel Adjuvant, MTP-PE/MF59
1996 • 72 citations
A Dose-Ranging Study of a Prototype Synthetic HIV-1MN V3 Branched Peptide Vaccine
1996 • 68 citations
Memory Cytotoxic T Lymphocyte Responses in Human Immunodeficiency Virus Type 1 (HIV-1)-Negative Volunteers Immunized with a Recombinant Canarypox Expressing gp160 of HIV-1 and Boosted with a Recombinant gp160
1996 • 61 citations
IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp)
1995 • 52 citations
Oligoclonal CD8 Lymphocytes from Persons with Asymptomatic Human Immunodeficiency Virus (HIV) Type 1 Infection Inhibit DIV-1 Replication
1995 • 48 citations
Immune Responses Elicited by Recombinant Vaccinia-Human Immunodeficiency Virus (HIV) Envelope and HIV Envelope Protein: Analysis of the Durability of Responses and Effect of Repeated Boosting
1994 • 46 citations
HIV-2-specific cytotoxic T-lymphocyte activity is inversely related to proviral load
1995 • 46 citations
Repair of excisional wounds in the embryo
1994 • 30 citations
Kinetics of cytotoxic lymphocytes in efferent lymph from single lymph nodes following immunization with vaccinia virus.
1984 • 27 citations
Cytotoxic T Lymphocytes Specific for HIV-1 gp160 Antigen and Synthetic P18IIIBPeptide in an HLA-A11-Immunized Individual
1994 • 22 citations
Human cytotoxic T cell responses to vaccinia virus vaccination
1991 • 18 citations
Dixième Colloque des Cent Gardes
1995 • 6 citations